Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Kupiec

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Transplantation Proceedings|September 2, 2003
Interactions between pharmaceutical industry and academia revisited: the University of California at Los Angeles caseJ W Kupiec-Weglinski
Annals of Transplantation|January 1, 1996
Graft rejection in sensitized recipientsJ W Kupiec-Wegliński
Transplantation|March 8, 2000
CD25-targeted therapy revisitedJ W Kupiec-Weglinski
Current Opinion in Immunology|October 6, 1999
What is the role of regulatory T cells in transplantation tolerance?Y Zhai, J W Kupiec-Weglinski
Clinical and Diagnostic Laboratory Immunology|November 1, 1995
Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individualsA Gorski, J W Kupiec-Weglinski
Current Gene Therapy|January 11, 2005
Gene therapy for the prevention of ischemia/reperfusion injury in organ transplantationT Ritter, J W Kupiec-Weglinski
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1997
Role of extracellular matrix proteins in organ transplantationJ W Kupiec-Weglinski, A Górski
Transplantation Reviews (Orlando, Fla.)|January 1, 1987
Use of cyclosporine in transplantation of nonprimarily vascularized tissuesE Towpik, J W Kupiec-Weglinski
Transplantation|August 1, 1981
Migration patterns of lymphocytes from recipients of organ allografts. I. The unmodified hostJ W Kupiec-Weglinski, N L Tilney
Immunology|February 1, 1991
Lymphocyte traffic is modified in vivo by anti-laminin antibodyJ W Kupiec-Weglinski, M De Sousa
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Transplantation Proceedings|September 2, 2003
Interactions between pharmaceutical industry and academia revisited: the University of California at Los Angeles caseJ W Kupiec-Weglinski
Annals of Transplantation|January 1, 1996
Graft rejection in sensitized recipientsJ W Kupiec-Wegliński
Transplantation|March 8, 2000
CD25-targeted therapy revisitedJ W Kupiec-Weglinski
Current Opinion in Immunology|October 6, 1999
What is the role of regulatory T cells in transplantation tolerance?Y Zhai, J W Kupiec-Weglinski
Clinical and Diagnostic Laboratory Immunology|November 1, 1995
Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individualsA Gorski, J W Kupiec-Weglinski
Current Gene Therapy|January 11, 2005
Gene therapy for the prevention of ischemia/reperfusion injury in organ transplantationT Ritter, J W Kupiec-Weglinski
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1997
Role of extracellular matrix proteins in organ transplantationJ W Kupiec-Weglinski, A Górski
Transplantation Reviews (Orlando, Fla.)|January 1, 1987
Use of cyclosporine in transplantation of nonprimarily vascularized tissuesE Towpik, J W Kupiec-Weglinski
Transplantation|August 1, 1981
Migration patterns of lymphocytes from recipients of organ allografts. I. The unmodified hostJ W Kupiec-Weglinski, N L Tilney
Immunology|February 1, 1991
Lymphocyte traffic is modified in vivo by anti-laminin antibodyJ W Kupiec-Weglinski, M De Sousa
Pageof 23